Wednesday, April 17, 2024 Apr 17, 2024
80° F Dallas, TX

Newsweek Calls Mark Cuban Cost Plus Drug Co. a ‘Medical Marvel’

The innovative pharmaceutical company is one of ten disruptive healthcare innovators named by the magazine.
Dr Alex Oshmyansky
Steven Visneau

Newsweek magazine named Alex Oshmyansky and Mark Cuban as “Great Disruptors” of the healthcare industry for the company’s work revolutionizing the pharmaceutical industry. The two founded the Mark Cuban Cost Plus Drug Co., which aims to provide transparent pricing and help bring drugs to market that aren’t profitable for major pharmaceutical companies.

The magazine said the disruptors carry the “spirit of medical inquiry into the current age” and noted the company’s industry disruption. With around one in three Americans skipping medications because of cost, Oshmyansky was moved to find a solution. D Magazine profiled the practicing radiologist and his incredible career (including his academic progression as a literal child prodigy) last year. After several fast starts and other entrepreneurial endeavors, Oshmyasnky sent a cold email to Dallas Mavericks owner and “Shark Tank” star Mark Cuban, who responded, and the two began to build a business.

The company works directly with drug manufacturers to deliver medications directly to consumers, cutting out intermediaries like inefficient and opaque pharmacy benefit managers. The result is selling medicines at a fraction of the cost. Newsweek highlighted the cholesterol medication Rosuvastatin, which sells for $5.10 on the company’s site and more than $110 at other pharmacies.

The company offers more than 1,200 on its online pharmacy, and the response has been robust. 1.3 million people created accounts in the company’s first 10 months, and sales topped $25 million in the first nine months. The company puts its pricing formula on the website, selling the drugs at cost plus a 15 percent markup for operating expenses and $8 for pharmacy and shipping fees.

More recently, the company has started working with insurance companies and employers by working with a transparent manager to allow companies to subsidize their employees’ pharmacy costs by working with Cost Plus. The company also has a pharmaceutical finish and fill facility in Deep Ellum that manufactures medications that are not profitable or in short supply.

Newsweek reports that next month, the company will sell its first biosimilar drug, Yusimry, an alternative to Humira, one of the bestselling medications of all time that treats several immune disorders. It will offer the medicine for $559.27, less than a tenth of the cost of Humira. Upon the announcement, Cuban tweeted: “The game has just changed.”

Newsweek’s list included everything from Magic Mushrooms and $1 Hearing Aids to improving women’s health. See all the below:

You can read about the Medical Marvels here.


Will Maddox

Will Maddox

View Profile
Will is the senior writer for D CEO magazine and the editor of D CEO Healthcare. He's written about healthcare…

Related Articles


Convicted Dallas Anesthesiologist Could Face 190 Years for ‘Toxic Cocktails’ in IV Bags

Dr. Raynaldo Ortiz worked at the Baylor Scott & White Health facility after spending time in jail for shooting a dog and while having a suspended medical license.
Ask the Expert

I’m Considering A Tummy Tuck. What Do I Need To Know?

Renowned surgeon Steven J. White offers advice for patients seeking this popular option.

The Local Hospital Using Heat to Treat Cancer

First Baptist Medical Center is one of the only places in the country offering the innovative treatment.